{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:29:04Z","timestamp":1790342944999,"version":"4.1.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic and acute pain are major comorbidities of sickle cell disease (SCD). Both peripheral and central nervous system mechanisms underlie SCD pain. We investigated the potential roles of endogenous fatty acyl derivatives with endocannabinoid-like activity; using targeted lipidomics of fatty acid ethanolamides and monoacylglycerols, we observed significant reduction of spinal palmitoylethanolamide (PEA) in the humanized, transgenic sickle (HbSS)\u2013BERK mouse model of SCD when compared with healthy HbAA control mice. PEA is a paracannabinoid lipid mediator that acts as a putative mast cell stabilizer and has been evaluated clinically for mechanical, cold, and joint pain, which are all features of SCD pain. Increased p38-MAPK activity in the spinal cord and dorsal root ganglia (DRG) neurons, and cutaneous mast cell activation, contribute to chronic hyperalgesia in sickle cell mice. We provide the first evidence that inhibiting endogenous PEA degradation and administration of exogenous PEA, reduces measures of chronic hyperalgesia via inhibition of peripheral and central mechanisms of pain hypersensitivity in sickle cell mice. PEA alleviated spinal inflammation, oxidative stress, and p38-MAPK activity; in the periphery, inhibited p38-MAPK phosphorylation and nuclear translocation in DRG neurons, reduced mast cell extracellular trap formation, and markers of inflammation in HbSS mice. In addition, PEA treatment prevented and ameliorated acute hyperalgesia incited by hypoxia\/reoxygenation challenge in sickle cell mice. Pain may persist even after hydroxyurea and curative therapies in SCD. PEA displayed safety in several clinical studies and has the translational potential to treat pain in SCD without the burden of additional medications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015439","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T22:30:46Z","timestamp":1741991446000},"page":"3056-3068","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["Neuroprotective, anti-inflammatory, and analgesic activity of palmitoylethanolamide in sickle cell mice"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-141X","authenticated-orcid":false,"given":"Donovan A.","family":"Argueta","sequence":"first","affiliation":[{"name":"1Division of Hematology & Oncology, Department of Medicine, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-2060","authenticated-orcid":false,"given":"Bryant","family":"Avalos","sequence":"additional","affiliation":[{"name":"2Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1224-9271","authenticated-orcid":false,"given":"Yugal","family":"Goel","sequence":"additional","affiliation":[{"name":"1Division of Hematology & Oncology, Department of Medicine, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Tran","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Oncology, and Transplantation, School of Medicine, University of Minnesota, Twin Cities, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-2009","authenticated-orcid":false,"given":"Yannick","family":"Fotio","sequence":"additional","affiliation":[{"name":"4Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-774X","authenticated-orcid":false,"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[{"name":"4Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8423-0695","authenticated-orcid":false,"given":"Nicholas V.","family":"DiPatrizio","sequence":"additional","affiliation":[{"name":"2Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-9979","authenticated-orcid":false,"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"1Division of Hematology & Oncology, Department of Medicine, University of California, Irvine, Irvine, CA"},{"name":"3Division of Hematology, Oncology, and Transplantation, School of Medicine, University of Minnesota, Twin Cities, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"4537","key":"2025062410415300100_bib1","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin","volume":"178","author":"Ingram","year":"1956","journal-title":"Nature"},{"issue":"10","key":"2025062410415300100_bib2","doi-asserted-by":"crossref","first-page":"104603","DOI":"10.1016\/j.jpain.2024.104603","article-title":"Unmet need: mechanistic and translational studies of sickle cell disease pain as a whole-person health challenge","volume":"25","author":"Belfer","year":"2024","journal-title":"J Pain"},{"issue":"10","key":"2025062410415300100_bib3","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1002\/ajh.25233","article-title":"Opioid utilization patterns in United States individuals with sickle cell disease","volume":"93","author":"Ballas","year":"2018","journal-title":"Am J Hematol"},{"issue":"6","key":"2025062410415300100_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/j.pain.0000000000002479","article-title":"Intraindividual pain variability and phenotypes of pain in sickle cell disease: a secondary analysis from the pain in sickle cell epidemiology study","volume":"163","author":"Bakshi","year":"2022","journal-title":"Pain"},{"issue":"5","key":"2025062410415300100_bib5","doi-asserted-by":"crossref","first-page":"e194410","DOI":"10.1001\/jamanetworkopen.2019.4410","article-title":"Management of chronic pain in adults living with sickle cell disease in the era of the opioid epidemic: a qualitative study","volume":"2","author":"Sinha","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2025062410415300100_bib6","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1002\/cpns.54","article-title":"Mouse models of pain in sickle cell disease","volume":"85","author":"Sagi","year":"2018","journal-title":"Curr Protoc Neurosci"},{"issue":"5339","key":"2025062410415300100_bib7","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"P\u00e1szty","year":"1997","journal-title":"Science"},{"issue":"2","key":"2025062410415300100_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat Neurosci"},{"issue":"suppl 1","key":"2025062410415300100_bib9","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"3","key":"2025062410415300100_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2025062410415300100_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.2011.08977.x","article-title":"Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness","volume":"156","author":"Cain","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"2025062410415300100_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2015.136523","article-title":"Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation","volume":"101","author":"Vincent","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"2025062410415300100_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.124.002285","article-title":"\u03949-Tetrahydrocannabinol alleviates hyperalgesia in a humanized mouse model of sickle cell disease","volume":"391","author":"Mabou Tagne","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"2025062410415300100_bib14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat Neurosci"},{"key":"2025062410415300100_bib15","doi-asserted-by":"crossref","first-page":"1263924","DOI":"10.3389\/fendo.2023.1263924","article-title":"The paracannabinoid system: endocannabinoid-like lipids and their functions [editorial]","volume":"14","author":"Passani","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2025062410415300100_bib16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"43","key":"2025062410415300100_bib17","doi-asserted-by":"crossref","first-page":"eabi8834","DOI":"10.1126\/sciadv.abi8834","article-title":"NAAA-regulated lipid signaling governs the transition from acute to chronic pain","volume":"7","author":"Fotio","year":"2021","journal-title":"Sci Adv"},{"issue":"6","key":"2025062410415300100_bib18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/nu15061350","article-title":"Palmitoylethanolamide in the treatment of chronic pain: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"15","author":"Lang-Illievich","year":"2023","journal-title":"Nutrients"},{"issue":"8030","key":"2025062410415300100_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/d41586-024-02994-2","article-title":"Doctors cured her sickle-cell disease. So why is she still in pain?","volume":"633","author":"Ledford","year":"2024","journal-title":"Nature"},{"issue":"15","key":"2025062410415300100_bib20","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMp2301143","article-title":"Treating chronic pain in sickle cell disease - the need for a biopsychosocial model","volume":"388","author":"Childerhose","year":"2023","journal-title":"N Engl J Med"},{"key":"2025062410415300100_bib21","doi-asserted-by":"crossref","first-page":"q2147","DOI":"10.1136\/bmj.q2147","article-title":"Sickle cell drug is withdrawn over safety concerns just months after rollout","volume":"387","author":"Mahase","year":"2024","journal-title":"BMJ"},{"issue":"6","key":"2025062410415300100_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ajh.27275","article-title":"Crizanlizumab and sickle cell disease: when should medications have their approval status revoked?","volume":"99","author":"Jacobs","year":"2024","journal-title":"Am J Hematol"},{"issue":"6953","key":"2025062410415300100_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"issue":"9","key":"2025062410415300100_bib24","doi-asserted-by":"crossref","first-page":"E1409","DOI":"10.1210\/jc.2011-0647","article-title":"2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans","volume":"96","author":"Hansen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025062410415300100_bib25","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41467-024-46139-5","article-title":"NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice","volume":"15","author":"Fotio","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"2025062410415300100_bib26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3324\/haematol.2015.137489","article-title":"Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice","volume":"101","author":"Valverde","year":"2016","journal-title":"Haematologica"},{"key":"2025062410415300100_bib27","doi-asserted-by":"crossref","first-page":"104686","DOI":"10.1016\/j.neuint.2020.104686","article-title":"Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal rats","volume":"135","author":"Hsieh","year":"2020","journal-title":"Neurochem Int"},{"issue":"1","key":"2025062410415300100_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1871527311312010009","article-title":"Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial\/microglial phenotypical changes in mice","volume":"12","author":"Luongo","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"2025062410415300100_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/ars.2019.7913","article-title":"Heme causes pain in sickle mice via Toll-like receptor 4-mediated reactive oxygen species- and endoplasmic reticulum stress-induced glial activation","volume":"34","author":"Lei","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"2025062410415300100_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"issue":"3","key":"2025062410415300100_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1567202618666210920115716","article-title":"NEP1-40-overexpressing neural stem cells enhance axon regeneration by inhibiting Nogo-A\/NgR1 signaling pathway","volume":"18","author":"Zhang","year":"2021","journal-title":"Curr Neurovasc Res"},{"issue":"4","key":"2025062410415300100_bib32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/j.pain.0000000000000104","article-title":"Sensitization of nociceptive spinal neurons contributes to pain in a transgenic model of sickle cell disease","volume":"156","author":"Cataldo","year":"2015","journal-title":"Pain"},{"key":"2025062410415300100_bib33","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.2147\/JPR.S210196","article-title":"Substance P modulates electroacupuncture analgesia in humanized mice with sickle cell disease","volume":"12","author":"Wang","year":"2019","journal-title":"J Pain Res"},{"issue":"2","key":"2025062410415300100_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuro.2009.01.003","article-title":"Role of MAPKs in platinum-induced neuronal apoptosis","volume":"30","author":"Scuteri","year":"2009","journal-title":"Neurotoxicology"},{"issue":"11","key":"2025062410415300100_bib35","doi-asserted-by":"crossref","first-page":"e202402788","DOI":"10.26508\/lsa.202402788","article-title":"Mast cell extracellular trap formation underlies vascular and neural injury and hyperalgesia in sickle cell disease","volume":"7","author":"Argueta","year":"2024","journal-title":"Life Sci Alliance"},{"issue":"11","key":"2025062410415300100_bib36","doi-asserted-by":"crossref","first-page":"e79923","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"2025062410415300100_bib37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jpain.2015.07.005","article-title":"Frequency of hospitalizations for pain and association with altered brain network connectivity in sickle cell disease","volume":"16","author":"Darbari","year":"2015","journal-title":"J Pain"},{"issue":"1","key":"2025062410415300100_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1208\/s12248-008-9075-y","article-title":"Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J"},{"issue":"2","key":"2025062410415300100_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/jpet.121.000674","article-title":"Antinociceptive profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a novel orally active","volume":"378","author":"Fotio","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"2025062410415300100_bib40","doi-asserted-by":"crossref","first-page":"170051","DOI":"10.1038\/sdata.2017.51","article-title":"Transcriptomic analysis of gene signatures associated with sickle pain","volume":"4","author":"Paul","year":"2017","journal-title":"Sci Data"},{"issue":"1","key":"2025062410415300100_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12622","article-title":"Mast cell-neural interactions contribute to pain and itch","volume":"282","author":"Gupta","year":"2018","journal-title":"Immunol Rev"},{"issue":"11","key":"2025062410415300100_bib50","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2025062410415300100_bib42","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12974-019-1671-5","article-title":"Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity","volume":"16","author":"Petrosino","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2025062410415300100_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41419-020-2239-0","article-title":"Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl\/6 mice","volume":"11","author":"Huehnchen","year":"2020","journal-title":"Cell Death Dis"},{"key":"2025062410415300100_bib44","doi-asserted-by":"crossref","first-page":"4585704","DOI":"10.1155\/2020\/4585704","article-title":"Sickle cell anemia patients display an intricate cellular and serum biomarker network highlighted by TCD4+CD69+ lymphocytes, IL-17\/MIP-1","volume":"2020","author":"Garcia","year":"2020","journal-title":"J Immunol Res"},{"issue":"9","key":"2025062410415300100_bib45","doi-asserted-by":"crossref","first-page":"e20191430","DOI":"10.1084\/jem.20191430","article-title":"Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases","volume":"217","author":"Mailhot","year":"2020","journal-title":"J Exp Med"},{"issue":"3","key":"2025062410415300100_bib46","doi-asserted-by":"crossref","first-page":"e92073","DOI":"10.1371\/journal.pone.0092073","article-title":"Gene therapy for neuropathic pain by silencing of TNF-\u03b1 expression with lentiviral vectors targeting the dorsal root ganglion in mice","volume":"9","author":"Ogawa","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"2025062410415300100_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jpain.2010.08.003","article-title":"Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice","volume":"12","author":"Kim","year":"2011","journal-title":"J Pain"},{"issue":"1","key":"2025062410415300100_bib48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/iid3.211","article-title":"Interferon \u03b12 and interferon \u03b3 induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells","volume":"6","author":"Oldford","year":"2018","journal-title":"Immun Inflamm Dis"},{"key":"2025062410415300100_bib49","first-page":"CD004344","article-title":"Treatment for avascular necrosis of bone in people with sickle cell disease","volume":"12","author":"Mart\u00ed-Carvajal","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2025062410415300100_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bjh.14300","article-title":"Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use","volume":"175","author":"Brandow","year":"2016","journal-title":"Br J Haematol"},{"key":"2025062410415300100_bib52","doi-asserted-by":"crossref","first-page":"154933","DOI":"10.1016\/j.cyto.2019.154933","article-title":"Pro-inflammatory cytokines associate with NETosis during sickle cell vaso-occlusive crises","volume":"127","author":"Barbu","year":"2020","journal-title":"Cytokine"},{"issue":"10","key":"2025062410415300100_bib53","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00213-018-4982-9","article-title":"Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia","volume":"235","author":"Holubiec","year":"2018","journal-title":"Psychopharmacology"},{"issue":"3","key":"2025062410415300100_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000321791","article-title":"Plasma glial fibrillary acidic protein levels in a child with sickle cell disease and stroke","volume":"125","author":"Savage","year":"2011","journal-title":"Acta Haematol"},{"issue":"4","key":"2025062410415300100_bib55","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/bcp.13020","article-title":"Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy","volume":"82","author":"Gabrielsson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2025062410415300100_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","article-title":"Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies","volume":"4","author":"Del Giorno","year":"2015","journal-title":"Pain Ther"},{"issue":"6","key":"2025062410415300100_bib57","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000536670","article-title":"Efficacy of topical palmitoylethanolamide (Levagen+) for the management of eczema symptoms: a double-blind, comparator-controlled, randomized clinical trial","volume":"36","author":"Rao","year":"2023","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"2025062410415300100_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1091581820986073","article-title":"Palmitoylethanolamide: prenatal developmental toxicity study in rats","volume":"40","author":"Deshmukh","year":"2021","journal-title":"Int J Toxicol"},{"issue":"5","key":"2025062410415300100_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/3056\/2380101\/blooda_adv-2024-015439-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/3056\/2380101\/blooda_adv-2024-015439-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:48:10Z","timestamp":1750776490000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/12\/3056\/536048\/Neuroprotective-anti-inflammatory-and-analgesic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015439","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,24]]},"published":{"date-parts":[[2025,6,16]]}}}